Document is current
Any future updates will be listed below
-
Authors
Cortes, Jorge
-
Funding
Funding for this research was provided by:
Daiichi Sankyo Company
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 3 October 2024
First Online: 13 November 2024
Declarations
:
: Not applicable.
: Not applicable.
: JC reports research grants from AbbVie, Daiichi Sankyo, Novartis, Sun Pharma, and Pfizer; consulting fees from AbbVie, Bio-Path, Daiichi Sankyo, Gilead, Forma Therapeutics, Novartis, Pfizer, and Takeda; payment for lectures or speakers bureaus from Novartis, Pfizer, and Takeda; and has stock options with Bio-Path.
